SymBiosis
Chidozie Ugwumba is currently the Managing Partner at SymBiosis Capital Management and serves as a Board Member or Observer at various biotechnology companies such as Biosplice Therapeutics, Carisma Therapeutics, Micronoma, Clene Nanomedicine, PlateletBio, MaaT Pharma, and Enterome. With a background in business administration and political science from Cornell Johnson Graduate School of Management, Amherst College, and Phillips Academy, Chidozie has also held positions at WIT, LLC and Partners Group in the past.
This person is not in any teams
SymBiosis
SymBiosis is an investment firm focused on advancing biotherapeutics innovations for serious and life-threatening diseases. The firm invests in groundbreaking medicines across disease area, financing stage, and geography, with a focus on programs in, or about to enter, human trials. SymBiosis currently manages a portfolio of more than 30 investments and has significant, long-term capital commitments to fund future investments.